How to analyze the anticoagulant and antithrombotic mechanisms of action in fucanome and galactanome?

Glycoconjugate Journal

Volumn 31, Issue 2, 2014, Pages 89-99

  Pomin, Vitor H ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Drug development; Glycomics; Sulfated fucan; Sulfated galactan; Thrombosis

Indexed keywords

ANTICOAGULANTS; FIBRINOLYTIC AGENTS; GALACTANS; GLYCOMICS; HUMANS; POLYSACCHARIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84895153416     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-013-9509-3     Document Type: Article

References (26)

1. Pomin, V.H.: Fucanomics and galactanomics: marine distribution, medicinal impact, conceptions, and challenges. Mar Drugs 10, 793-811 (2012)
2. Pomin, V.H.: Fucanomics and galactanomics: current status in drug discovery, mechanisms of action and role of the well-defined structures. Bioch Biophys Acta - Gen Subj 1820, 1971-1979 (2012)
3. Pomin, V.H., Mourão, P.A.: Structure, biology, evolution and medical importance of sulfated fucans and galactans. Glycobiol 18, 1016-1027 (2008)
4. Pomin, V.H.: Review: An overview about the structure-function relationship of marine sulfated homopolysaccharides with regular chemical structures. Biopol 91, 601-609 (2009)
5. Berteau, O., Mulloy, B.: Sulfated fucans, fresh perspectives: Structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiol 13, 29R-40R (2003)
6. Mourão, P.A.: Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives. Curr Pharm Des 10, 967-981 (2004)
7. Cumashi, A., Ushakova, N.A., Preobrazhenskaya, M.E., Piccoli, A., Totani, L., Ustyuzhanina, N.E., Bilan, M.I., Usov, A.I., Grachev, A.A., Morozevich, G.E., et al.: A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiol 17, 541-552 (2007)
8. Rodrigues, J.A., Vanderlei, E.S., Silva, L.M., Araújo, I.W., Queiroz, I.N., Paula, G.A., Abreu, T.M., Ribeiro, N.A., Bezerra, M.M., Chaves, H.V., Lima, V., Jorge, R.J., Monteiro, H.S., Leite, E.L., Benevides, N.M.: Antinociceptive and anti-inflammatory activities of a sulfated polysaccharide isolated from the green seaweed Caulerpa cupressoides. Pharmacol Rep 64, 282-292 (2012)
9. Dore, C.M., das C Faustino Alves, M.G., Will, L.S., Costa, T.G., Sabry, D.A., de Souza Rêgo, L.A., Accardo, C.M., Rocha, H.A., Filgueira, L.G., Leite, E.L.: A sulfated polysaccharide, fucans, isolated from brown algae Sargassum vulgare with anticoagulant, antithrombotic, antioxidant and anti-inflammatory effects. Carbohydr Polym 91, 467-475 (2013)
10. Romanos, M.T., Andrada-Serpa, M.J., Mourão, P.A., Yoneshigue-Valentin, Y., Costa, S.S., Pereira, M.S., Miranda, M.M., Gonçalves, J.L., Wigg, M.D.: A sulphated fucan from the Laminaria abyssalis inhibits the human T cell lymphotropic virus type 1-induced syncytium formation in HeLa cells. Antivir Chem Chemother 13, 219-221 (2002)
11. Croci DO, Cumashi A, Ushakova NA, Preobrazhenskaya ME, Piccoli A, et al.: Fucans, but not fucomannoglucuronaans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed. Plos One 6, e17283
12. Koyanagi, S., Tanigawa, N., Nakagawa, H., Soeda, S., Shimeno, H.: Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Bioch Pharmacol 65, 173-179 (2003)
13. Pallister CJ, Watson MS: Haematology 2010; Scion Publishing. 2nd edition. pp. 336-347.
14. Pereira, M.S., Mulloy, B., Mourão, P.A.: Structure and anticoagulant activity of sulfated fucans. Comparison between the regular, repetitive, and linear fucans from echinoderms with the more heterogeneous and branched polymers from brown algae. J Biol Chem 274, 7656-7667 (1999)
15. Andersson, L.O., Barrowcliffe, T.W., Holmer, E., Johnson, E.A., Sims, G.E.: Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration. Thromb Res 9, 575-583 (1976)
16. Matsubara, K., Matsuura, Y., Bacic, A., Liao, M., Hori, K., Miyazawa, K.: Anticoagulant properties of a sulfated galactan preparation from a marine green alga, Codium cylindricum. Int J Biol Macromol 28, 395-399 (2001)
17. Matsubara, K., Matsuura, Y., Hori, K., Miyazawa, K.: An anticoagulant proteoglycan from the marine green alga, Codium pugniformis. J Appl Phycol 12, 9-14 (2000)
18. Maraganore, J.M., Chao, B., Joseph, M.L., Jablonski, J., Ramachandran, K.L.: Anticoagulant activity of synthetic hirudin peptides. J Biol Chem 264, 8692-8698 (1989)
19. Pereira, M.S., Melo, F.R., Mourão, P.A.: Is there a correlation between structure and anticoagulant action of sulfated galatans and sulfated fucans? Glycobiol 12, 573-580 (2002)
20. Fonseca, R.J., Oliveira, S.N., Melo, F.R., Pereira, M.G., Benevides, N.M., Mourão, P.A.: Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities. Thromb Haemost 99, 539-545 (2008)
21. Fonseca, R.J., Oliveira, S.N., Pomin, V.H., Mecawi, A.S., Araujo, I.G., Mourão, P.A.: Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges for the study of anticoagulant polysaccharides. Thromb Haemost 103, 994-1004 (2010)
22. Glauser, B.F., Vairo, B.C., Oliveira, S.N., Cinelli, L.P., Pereira, M.S., Mourão, P.A.: Structure and haemostatic effects of generic versions of enoxaparin available for clinical use in Brazil: similarity to the original drug. Thromb Haemost 107, 302-14 (2012)
23. Eitzman, D.T., Westrick, R.J., Nabel, E.G., et al.: Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 95, 577-580 (2000)
24. Wessler, S., Reimer, S.M., Sheps, M.C.: Biological assay of a thrombosis inducing activity in human serum. J Appl Physiol 14, 943-946 (1959)
25. Herbert, J.M., Bernat, A., Maffrand, J.P.: Importance of platelets in experimental venous thrombosis in rats. Blood 80, 2281-2286 (1992)
26. Mourão, P.A., Pereira, M.S.: Searching for alternatives to heparin: sulfated fucans from marine invertebrates. Trends Cardiovasc Med 9, 225-32 (1999)